Form CT ORDER - Confidential treatment order:
SEC Accession No. 9999999997-20-002395
Filing Date
2020-05-01
Accepted
2020-05-01 14:40:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf CT ORDER 89023
  Complete submission text file 9999999997-20-002395.txt   123855
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CT ORDER | Act: 34 | File No.: 000-23186 | Film No.: 20840164
SIC: 2836 Biological Products, (No Diagnostic Substances)